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Introduction
Pathologic uncertainty exists when an incidental renal mass is identified. Preoperative counseling and treatment planning are often made in the context of this uncertainty, despite the fact that 20-30% of these lesions ultimately prove benign and only 10-30% are found to be potentially aggressive [1] [2] [3] [4] . As such, the rising rates of renal surgery for the small renal mass (SRM) have yet to translate into a quantifiable survival benefit [5] . Although efforts have been made to assess malignant potential using preoperative variables, to date the clinical usefulness of nonextirpative diagnostic strategies including percutaneous biopsy and pathologic predictive models remains limited [6] [7] [8] .
Increasing evidence suggests a relationship may exist between renal mass anatomy and pathology [9] [10] [11] ; however, only recently have objective measures of defining renal mass anatomy been described [12] [13] [14] . Nephrometry is the first such scoring system to allow quantification of renal tumor anatomy in a reproducible manner [12] . Here we determined whether anatomic radiographic attributes of renal masses, as scored by Nephrometry, can predict the pathologic characteristics of enhancing renal masses. We also developed a predictive model integrating renal tumor anatomy with other demographic characteristics to predict tumor histology and grade.
Methods
Using the prospectively maintained Kidney Cancer Keystone database approved by our institutional review board, we identified all patients who underwent renal surgery at our institution with available Nephrometry scores. Demographic, clinical, pathologic, and crosssectional imaging characteristics were reviewed for all identified patients. Renal cell carcinoma stage was assigned by surgical pathology according to the American Joint Committee on Cancer 2002 TNM classification [15] . For the purposes of statistical analysis, tumors with
Fuhrman grade I and II were considered low grade, and grade III and IV tumors were classified as high grade. Tumor histology was assigned according to the 2004 World Health Organization criteria [16] .
Nephrometry scores (www.nephrometry.com; anatomic components of the Nephrometry scoring system. Marginally statistically significant sex and age associations at the p < 0.10 level were retained in the nomogram models to assure that we were appropriately controlling for possible confounding variables. Age was entered into the model via the use of restricted cubic splines with three knots placed at empirical quantiles [17] .
The predictive accuracy of the nomograms was quantified by receiver operating characteristic derived area under the curve (AUC)
estimates with 100% indicating perfect prediction and 50% equivalent to a coin toss. Nested nomogram models were compared using likelihood ratio tests. To evaluate the predictive characteristics of our nomograms more generally, we performed a simulation with 10 000 iterations in which we randomly split the sample into a training and test data set with each iteration (50% split with each iteration). The nomogram models were fit in the training sample, and the AUC was calculated on the test data set using the training data-set model.
To assess the calibration of our models, we used a ''leave one out prediction'' technique in which for each person we predicted their outcomes after using the rest of the sample's data to fit our models. We then grouped individuals into quintiles based on their predicted probabilities of having cancer or high-grade disease. Next, we examined the proportion within each quintile that actually had cancer or highgrade disease. We used a scatter plot of the observed versus average predicted proportions within each quintile in which the points should lie on a 45% line. Similar calibration was described previously [18] .
The analyses were conducted using Stata v.10 (StataCorp, College Station, TX, USA), and R v.2 (R Foundation for Statistical Computing, Vienna, Austria).
Results
A total of 1750 patients undergoing surgical treatment for renal masses between 1999 and 2009 were identified. Of this cohort, a calculated Nephrometry score based on available preoperative cross-sectional imaging was available for 525 renal masses (30%), all treated between 2007 and 2009. Table 2 summarizes the demographic, clinical, and pathologic variables. Total Nephrometry score and individual anatomic descriptor components significantly differed between highand low-grade tumors and tumor histology (Table 3) . Table  4 describes patient and tumor characteristics associated with malignant or high-grade features on multivariable analysis. Tumor size (R; p < 0.0001), exophycity (E; p = 0.041), and location in relation to the renal poles (L; p = 0.002) were associated with high-grade features.
Based on these data, we constructed a predictive nomogram integrating anatomic tumor attributes with patient's age and gender for preoperative prediction of tumor characteristics. The nomogram combines two independent models. The first model predicts likelihood of a given renal mass proving to be a malignancy upon resection; the second model generates a probability of the tumor being high grade if it is indeed a malignancy. Figure 1 shows the results of the model calibration, which demonstrates that the model is well calibrated. The full nomogram incorporating both the malignant and grade components is presented in Figure 2 and was operationalized for ease during clinical use at www.cancernomograms.com.
The AUC for the malignant versus benign model was calculated to be 0.76. If the individual Nephrometry score attributes were excluded from the model and only sex and age were considered, the AUC dropped to 0.69 ( 
Discussion
The enhancing renal mass is a heterogeneous clinical entity with varied biologic potential. The ability to match renal mass biology with an appropriate treatment strategy remains an elusive goal of modern urologic oncology [19] . Our results suggest that preoperative radiographic and anatomic attributes of renal masses possess predictive information regarding the mass's pathologic features. In this study we quantified anatomic complexity using the RENAL Nephrometry score, the first scoring system designed to assess pertinent renal tumor anatomy as it relates to surgical respectability [12] . Alternative systems including preoperative aspects and dimensions used for an anatomical (PADUA) classification and the centrality index (C index) have been reported. The PADUA system quantifies renal mass anatomic features that are similar to those captured by Nephrometry [13] , whereas the C index is a calculation that maps the tumor's relationship to the renal center [14] . The pretreatment assessment of enhancing renal mass pathology has been composed to date primarily of percutaneous biopsy. However, the use of renal biopsy has historically been limited due to risks, sampling error, and the relatively high frequency with which clinically irrelevant data are obtained [6] . The usefulness of percutaneous renal biopsy has been reexamined in select patients [20] , and modern series using 18-gauge core biopsies have reported improved accuracy in differentiating benign from malignant histologic types with minimal procedure-related complications [21] . When a malignancy is found on biopsy, the positive predictive value is reported to be >95%.
Negative predictive value appears to be >80% with most contemporary series reporting false-negative rates < 5% RCC = renal cell carcinoma; SD = standard deviation.
[6, [21] [22] [23] . Despite the reported accuracy of renal biopsy in determining histologic subtype, most modern series do not assess tumor grade [6] , which has significant established prognostic implications for cancer-specific survival [24] . In fact, two contemporary series using modern core biopsy techniques have reported distinction of tumor grading in only 62.7% of patients undergoing biopsy as part of an active surveillance protocol [25] . Underestimation of nuclear A = anterior; E = exophytic/endophytic; L = location; N = nearness; NS = nephrometry sum; P = posterior; R = radius; SD = standard deviation. * For each histologic subtype, the ranking was prioritized by the relative contribution of each individual anatomic attribute to overall Nephrometry score. For example, the total N score to the collecting system was statistically lower for papillary tumors than for other histologies, suggesting that papillary tumors less often abut the collecting system. Other refers to sarcomatoid, collecting duct, and other malignant histologic types. OR = odds ratio; CI = confidence interval; E = exophytic/endophytic; H = hilar; L = location; N = nearness; NS = nephrometry sum; R = radius; SD = standard deviation. * Although the model coefficients are not reported in this table, they were used to create the nomogram that allows for a visualization of the magnitude of the associations: n = 525 for malignant regression; n = 443* for high-grade regression. y Age was entered into the model after subtracting the minimum age (age minus 25) via a restricted cubic spline with three knots at empirical quantiles. The
Nephrometry component scores were entered as categorical dummy variables using the groupings shown in the nomograms. Where two terms were entered into the model for a variable, the p value represents the joint hypothesis test of both parameters. For example, two E components and two age spline terms were entered into the models. z Ten individuals with cancer but missing grade values were excluded from the high-versus low-grade analysis.
grade has been noted in more than half of the patients (55%) undergoing biopsy before surgical resection [26] . At the same time, recent studies suggesting that SRMs grow slowly and have low metastatic potential have led to increased interest in expectant management as an alternative to surgery in elderly patients and those with competing risks of mortality [27] . This has been supported by data suggesting that as many as 20-30% of SRMs < 2 cm are benign and that < 10-30% are high-grade malignancies [4] . It has been demonstrated that, as tumor size increases, there is a significantly greater probability of malignant versus benign pathology, high-grade versus low-grade disease, and clear cell versus papillary histology [28] [29] [30] . Using these data, algorithms have been developed with the aim of predicting the biologic potential of SRMs before intervention. For example, Lane et al constructed a nomogram based on the findings that gender, tumor size, and smoking history were predictive of malignant versus benign disease. However, the concordance index (CI) of this model was a modest 0.64. Furthermore, efforts to differentiate low-from high-grade cancers yielded a CI of 0.56, a model with an accuracy that is only slightly better than a flip of a coin [8] . Using a multi-institutional data set of European patients, Jeldres et al [7] also attempted to develop a tool to predict high grade (Fuhrman grade III-IV) features at nephrectomy, using four covariates: age at diagnosis, gender, tumor size, and symptom classification. Of these factors, only tumor size was significantly associated with high-grade disease on univariate analysis, and their multivariable model to predict high-grade disease was only 58.3% accurate [7] . Given the limitations of tumor size alone to predict pathology and hence biology, efforts to incorporate anatomic features for prediction of renal mass histology have been described as well. For example, Schachter et al reported that exophytic lesions were significantly more likely to be non-clear cell tumors when compared with central lesions ( p = 0.003), although no standardized definition of ''exophytic'' was provided [10] . In 123 patients undergoing laparoscopic partial nephrectomy, Venkatesh et al reported that only 55% of ''highly exophytic'' tumors were malignant, and of those, nearly all (96%) were low grade [11] .
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Integration of tumor anatomic attributes with patient age and gender resulted in a predictive model with an AUC of 0.76. In turn, the model for tumor grade resulted in an AUC of 0.73, which appears superior to previously described predictive models [7] . Although direct retrospective comparisons between different cohorts must be interpreted with extreme caution, the predictive ability of this nomogram appears to be similar to the accuracy of contemporary percutaneous biopsy results (approximately 70% accuracy) [25, 26] . The grade model appeared to largely retain its accuracy on out-of sample cross-validation. Our initial attempts at integrating preoperative imaging characteristics into a predictive model appear to offer a clinically useful and a robust tool that can help inform critical decision making. Although limited by relatively small sample size and lack of validation with an external data set, the model is the first of its kind to integrate quantifiable tumor anatomic data into a clinical instrument. Using the model, quantifiable probabilities of harboring malignant and high-grade pathology can be objectively compared with competing risks of comorbid medical conditions and the morbidity of treatment itself (Table 5 ).
Conclusions
The prediction of aggressive tumor characteristics to match treatment strategies to tumor biology remains a significant challenge for patients diagnosed with a SRM. Increasing evidence suggests that anatomic features may provide insight into renal tumor biology. We provide a quantitative tool using anatomic features as measured by Nephrometry and demographic features to predict tumor pathology. These data, although promising and novel, await external validation.
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